CVS Group plc (CVSGF) Stock Competitors & Peer Comparison
See (CVSGF) competitors and their performances in Stock Market.
Peer Comparison Table: Personal Products & Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CVSGF | $16.55 | +0.00% | 1.2B | 53.39 | $0.31 | +0.68% |
| PRRWF | $19.18 | -0.26% | 655.4M | -91.33 | -$0.21 | N/A |
| CRLKP | $22.50 | +0.00% | 498.7M | N/A | N/A | N/A |
| WOSSF | $0.15 | +31.91% | 98.7M | 7.26 | $0.02 | +5.31% |
| MIBE | $2.75 | +0.00% | 80.3M | N/A | N/A | N/A |
| MNLXF | $0.26 | +0.00% | 43.2M | -6.45 | -$0.04 | N/A |
| KVIL | $0.00 | +0.00% | 30.5M | N/A | N/A | N/A |
| GDDFF | $0.15 | +6.70% | 15.2M | -1.70 | -$0.09 | N/A |
| AMIH | $0.00 | +45.16% | 877.5K | N/A | $16.74 | N/A |
| GDET | $0.00 | +0.00% | 89.9K | -0.10 | -$0.00 | N/A |
Stock Comparison
CVSGF vs PRRWF Comparison June 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, PRRWF has a market cap of 655.4M. Regarding current trading prices, CVSGF is priced at $16.55, while PRRWF trades at $19.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.39, whereas PRRWF's P/E ratio is -91.33. In terms of profitability, CVSGF's ROE is +0.08%, compared to PRRWF's ROE of -0.01%. Regarding short-term risk, CVSGF is less volatile compared to PRRWF. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.Check PRRWF's competition here
CVSGF vs CRLKP Comparison June 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, CRLKP has a market cap of 498.7M. Regarding current trading prices, CVSGF is priced at $16.55, while CRLKP trades at $22.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.39, whereas CRLKP's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.08%, compared to CRLKP's ROE of +0.00%. Regarding short-term risk, CVSGF and CRLKP have similar daily volatility (0.00).Check CRLKP's competition here
CVSGF vs WOSSF Comparison June 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, WOSSF has a market cap of 98.7M. Regarding current trading prices, CVSGF is priced at $16.55, while WOSSF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.39, whereas WOSSF's P/E ratio is 7.26. In terms of profitability, CVSGF's ROE is +0.08%, compared to WOSSF's ROE of +0.25%. Regarding short-term risk, CVSGF and WOSSF have similar daily volatility (0.00).Check WOSSF's competition here
CVSGF vs MIBE Comparison June 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, MIBE has a market cap of 80.3M. Regarding current trading prices, CVSGF is priced at $16.55, while MIBE trades at $2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.39, whereas MIBE's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.08%, compared to MIBE's ROE of N/A. Regarding short-term risk, CVSGF and MIBE have similar daily volatility (0.00).Check MIBE's competition here
CVSGF vs MNLXF Comparison June 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, MNLXF has a market cap of 43.2M. Regarding current trading prices, CVSGF is priced at $16.55, while MNLXF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.39, whereas MNLXF's P/E ratio is -6.45. In terms of profitability, CVSGF's ROE is +0.08%, compared to MNLXF's ROE of +1.50%. Regarding short-term risk, CVSGF and MNLXF have similar daily volatility (0.00).Check MNLXF's competition here
CVSGF vs KVIL Comparison June 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, KVIL has a market cap of 30.5M. Regarding current trading prices, CVSGF is priced at $16.55, while KVIL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.39, whereas KVIL's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.08%, compared to KVIL's ROE of N/A. Regarding short-term risk, CVSGF and KVIL have similar daily volatility (0.00).Check KVIL's competition here
CVSGF vs GDDFF Comparison June 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, GDDFF has a market cap of 15.2M. Regarding current trading prices, CVSGF is priced at $16.55, while GDDFF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.39, whereas GDDFF's P/E ratio is -1.70. In terms of profitability, CVSGF's ROE is +0.08%, compared to GDDFF's ROE of +0.46%. Regarding short-term risk, CVSGF and GDDFF have similar daily volatility (0.00).Check GDDFF's competition here
CVSGF vs AMIH Comparison June 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, AMIH has a market cap of 877.5K. Regarding current trading prices, CVSGF is priced at $16.55, while AMIH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.39, whereas AMIH's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.08%, compared to AMIH's ROE of +0.64%. Regarding short-term risk, CVSGF is less volatile compared to AMIH. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.Check AMIH's competition here
CVSGF vs GDET Comparison June 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, GDET has a market cap of 89.9K. Regarding current trading prices, CVSGF is priced at $16.55, while GDET trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.39, whereas GDET's P/E ratio is -0.10. In terms of profitability, CVSGF's ROE is +0.08%, compared to GDET's ROE of +0.05%. Regarding short-term risk, CVSGF and GDET have similar daily volatility (0.00).Check GDET's competition here
CVSGF vs BZRT Comparison June 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, BZRT has a market cap of 53.5K. Regarding current trading prices, CVSGF is priced at $16.55, while BZRT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.39, whereas BZRT's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.08%, compared to BZRT's ROE of +0.00%. Regarding short-term risk, CVSGF and BZRT have similar daily volatility (0.00).Check BZRT's competition here
CVSGF vs AIOM Comparison June 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, AIOM has a market cap of 34K. Regarding current trading prices, CVSGF is priced at $16.55, while AIOM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.39, whereas AIOM's P/E ratio is -0.03. In terms of profitability, CVSGF's ROE is +0.08%, compared to AIOM's ROE of -0.10%. Regarding short-term risk, CVSGF is less volatile compared to AIOM. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.Check AIOM's competition here
CVSGF vs CTHRQ Comparison June 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, CTHRQ has a market cap of 15.9K. Regarding current trading prices, CVSGF is priced at $16.55, while CTHRQ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.39, whereas CTHRQ's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.08%, compared to CTHRQ's ROE of -0.22%. Regarding short-term risk, CVSGF and CTHRQ have similar daily volatility (0.00).Check CTHRQ's competition here
CVSGF vs PTTL Comparison June 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, PTTL has a market cap of 7.6K. Regarding current trading prices, CVSGF is priced at $16.55, while PTTL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.39, whereas PTTL's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.08%, compared to PTTL's ROE of -1.53%. Regarding short-term risk, CVSGF is less volatile compared to PTTL. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.Check PTTL's competition here
CVSGF vs PNGB Comparison June 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, PNGB has a market cap of 4.9K. Regarding current trading prices, CVSGF is priced at $16.55, while PNGB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.39, whereas PNGB's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.08%, compared to PNGB's ROE of +15.99%. Regarding short-term risk, CVSGF and PNGB have similar daily volatility (0.00).Check PNGB's competition here
CVSGF vs CVSC Comparison June 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, CVSC has a market cap of 1.7K. Regarding current trading prices, CVSGF is priced at $16.55, while CVSC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.39, whereas CVSC's P/E ratio is 0.01. In terms of profitability, CVSGF's ROE is +0.08%, compared to CVSC's ROE of N/A. Regarding short-term risk, CVSGF and CVSC have similar daily volatility (0.00).Check CVSC's competition here
CVSGF vs OBDP Comparison June 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, OBDP has a market cap of 163. Regarding current trading prices, CVSGF is priced at $16.55, while OBDP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.39, whereas OBDP's P/E ratio is 0.00. In terms of profitability, CVSGF's ROE is +0.08%, compared to OBDP's ROE of N/A. Regarding short-term risk, CVSGF and OBDP have similar daily volatility (0.00).Check OBDP's competition here
CVSGF vs PXRB Comparison June 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, PXRB has a market cap of 82. Regarding current trading prices, CVSGF is priced at $16.55, while PXRB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.39, whereas PXRB's P/E ratio is -0.00. In terms of profitability, CVSGF's ROE is +0.08%, compared to PXRB's ROE of N/A. Regarding short-term risk, CVSGF and PXRB have similar daily volatility (0.00).Check PXRB's competition here
CVSGF vs VLBI Comparison June 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, VLBI has a market cap of 11. Regarding current trading prices, CVSGF is priced at $16.55, while VLBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.39, whereas VLBI's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.08%, compared to VLBI's ROE of -0.54%. Regarding short-term risk, CVSGF is less volatile compared to VLBI. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.Check VLBI's competition here
CVSGF vs CPLT Comparison June 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, CPLT has a market cap of 2. Regarding current trading prices, CVSGF is priced at $16.55, while CPLT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.39, whereas CPLT's P/E ratio is 0.00. In terms of profitability, CVSGF's ROE is +0.08%, compared to CPLT's ROE of N/A. Regarding short-term risk, CVSGF and CPLT have similar daily volatility (0.00).Check CPLT's competition here
CVSGF vs SPRJ Comparison June 2026
CVSGF plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVSGF stands at 1.2B. In comparison, SPRJ has a market cap of 0. Regarding current trading prices, CVSGF is priced at $16.55, while SPRJ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVSGF currently has a P/E ratio of 53.39, whereas SPRJ's P/E ratio is N/A. In terms of profitability, CVSGF's ROE is +0.08%, compared to SPRJ's ROE of N/A. Regarding short-term risk, CVSGF is less volatile compared to SPRJ. This indicates potentially lower risk in terms of short-term price fluctuations for CVSGF.Check SPRJ's competition here